Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Authors

Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F, and theDisCoVeRy Study Group

Publication date

Tue 22/02/2022 - 12:00

Ecrin position

ECRIN supported project

Link

https://www.thelancet.com/article/S1473-3099(21)00485-0/fulltext#%20

Journal reference

The Lancet Infectious Diseases